glp-1 supply news today drugs like Ozempic and Wegovy could become the new 'everything drug' GLP-1 Agonists Market Report 2025-2033,
Description
These products are not drugs, foods, cosmetics, or dietary supplements, have not been evaluated by the FDA, and are not intended for human or animal use
On April 30, 2026, the FDA took the more sweeping step of proposing to permanently exclude semaglutide, tirzepatide and liraglutide from the 503B Bulks List the list of ingredients that large-scale compounding facilities are legally permitted to use
Wegovy's 5.1 inches
[DOI] [PMC free article] [PubMed] [Google Scholar] 15.Athauda D, et al
Biochem Biophys Res Commun (2018) 506(4):97682
